James Jogerst
Corporate Officer/Principal chez RUBIUS THERAPEUTICS
Provenance du réseau au premier degré de James Jogerst
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Private Company | Biotechnology | 25 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à James Jogerst via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| INCYTE CORPORATION | Pharmaceuticals: Major | President Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | President Public Communications Contact | |
| SEAGEN INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Chief Executive Officer | |
| RADIUS HEALTH, INC. | Biotechnology | Founder Director of Finance/CFO | |
| GALAPAGOS NV | Biotechnology | Director/Board Member | |
| SYNCONA LIMITED | Investment Trusts/Mutual Funds | Chief Executive Officer | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Investor Relations Contact Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Flagship Pioneering
 Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Chief Executive Officer Consultant / Advisor Corporate Officer/Principal Private Equity Investor | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
| Massachusetts Institute of Technology | College/University | Director/Board Member Graduate Degree | |
| Villanova University | College/University | Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Doctorate Degree | |
| University of Copenhagen | College/University | Doctorate Degree | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ADVANCED ACCELERATOR APPLICATION SA(ADR) | Medical Specialties | Chairman | |
| AXCA HEALPAR | Biotechnology | Chief Executive Officer Founder Director/Board Member Chairman Director/Board Member | |
| Columbia Business School | College/University | Masters Business Admin Masters Business Admin | |
| Ernest Mario School of Pharmacy | College/University | Undergraduate Degree | |
| EVELO BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer Founder Chairman | |
| INNOCOLL HOLDINGS PLC | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Vetter Pharma International GmbH
 Vetter Pharma International GmbH Medical DistributorsDistribution Services Part of Vetter Pharma-Fertigung Verwaltungs GmbH, Vetter Pharma International GmbH is a pharmaceutical service provider that offers comprehensive fill-and-finish services from clinical development to commercialization and beyond. The company is based in Ravensburg, Germany. The German company uses robust, well-controlled testing procedures to verify the quality of every product they release. Vetter is a family-owned company that provides expert manufacturing guidance for injectable drug products. The company has an exclusive collection of in-depth videos that customers can explore. Recently, they responded to increasing market demand by implementing additional equipment for aseptic production and expanding storage capacities at the clinical site. The company was founded in 2009, and the CEO is Peter Sölkner. | Medical Distributors | Director/Board Member | |
Cellestia Biotech AG
 Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Ohana Biosciences, Inc.
 Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ohana Biosciences, Inc. operates early stage biotechnology firm. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member | |
CIBA Vision GmbH (Germany)
 CIBA Vision GmbH (Germany) Electronic ComponentsElectronic Technology Part of Alcon AG, CIBA Vision GmbH is a company based in Grosswallstadt, Germany. CIBA Vision GmbH manufactures and markets contact lenses. The German company was founded in 1983. The CEO is Norbert Dörr. | Electronic Components | Director/Board Member | |
Cobalt Biomedicine, Inc.
 Cobalt Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Cobalt Biomedicine, Inc. engages in the development of therapeutic based drugs. The company was founded in 2017 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ring Therapeutics, Inc. engages in the development of a gene therapy platform. Its Anellovector platform provides tissue specifities benefitting from the inherent diversity of tropism afforded by the commensal virome. The company was founded in 2000 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Repertoire Immune Medicines, Inc.
 Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Founder | |
Pelican Harbor Seabird Station, Inc.
 Pelican Harbor Seabird Station, Inc. Agricultural Commodities/MillingProcess Industries Pelican Harbor Seabird Station, Inc. is an animal care organization that focuses on the rehabilitation of vultures, which are the only known obligate scavengers in the world. Pelican Harbor Seabird Station is based in Miami. The organization offers behind-the-scenes tours, honorary adoptions, internships, and school & camp presentations. The American company also provides resources & referrals, seabird cruises, and self-guided audio tours. In addition, they have a photobiomodulation (PBMT) program that uses light therapy to relieve pain and inflammation. | Agricultural Commodities/Milling | Chairman | |
| OPY ACQUISITION CORP. I | Financial Conglomerates | Director/Board Member | |
| Three Opinions Foundation, Inc. | Director/Board Member | ||
| SENTI BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Artbio, Inc.
 Artbio, Inc. Hospital/Nursing ManagementHealth Services Artbio, Inc. is a company that is focused on redefining cancer care by developing a new class of alpha radioligand therapies (ART) and building an ecosystem that maximizes their potential. Artbio is based in Cambridge, MA and has subsidiaries in Norway. The company puts the patient at the core of everything they do. The company was founded in 2021 by Emanuele Ostuni, Roy Hartvig Larsen, and Øyvind Sverre Bruland. Emanuele Ostuni has been the CEO since 2021. | Hospital/Nursing Management | Director/Board Member | |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 35 |
| Allemagne | 5 |
| Danemark | 4 |
| Royaume-Uni | 4 |
| Suisse | 3 |
Sectorielle
| Health Technology | 31 |
| Consumer Services | 7 |
| Finance | 5 |
| Commercial Services | 4 |
| Miscellaneous | 2 |
Opérationnelle
| Director/Board Member | 169 |
| Corporate Officer/Principal | 67 |
| Founder | 46 |
| Independent Dir/Board Member | 44 |
| Chairman | 38 |
Relations les plus connectées
| Insiders | |
|---|---|
| Noubar Afeyan | 76 |
| Michael Rosenblatt | 31 |
| David Epstein | 28 |
| Catherine Sohn | 27 |
| Pablo Cagnoni | 24 |
| Jonathan Symonds | 24 |
| Craig Jalbert | 20 |
| Anne Prener | 14 |
| Susanne Antonie Schaffert | 13 |
| Natalie Holles | 13 |
| Jose Carmona | 10 |
| Laurence Turka | 10 |
| Francis Cuss | 9 |
| Maiken Keson-Brookes | 8 |
| Dannielle Appelhans | 7 |
- Bourse
- Insiders
- James Jogerst
- Connexions Sociétés
